Aarti Drugs Limited (BOM:524348)
India flag India · Delayed Price · Currency is INR
423.50
+10.90 (2.64%)
At close: Jul 31, 2026

Aarti Drugs Balance Sheet

Millions INR. Fiscal year is Apr - Mar.

Assets

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash & Equivalents
-88.175.6194.3289.6223.3
Short-Term Investments
-154.7145.82108.89113.3120.51
Cash & Short-Term Investments
242.8242.8221.43203.2202.89343.81
Cash Growth
7.39%9.65%8.97%0.15%-40.99%56.39%
Accounts Receivable
-8,2997,5127,0468,6487,499
Other Receivables
--188.2147.1739.116.98
Receivables
-8,3067,7087,0958,6917,506
Inventory
-4,9084,7294,8595,1635,259
Other Current Assets
-1,221725.31,050861.42824.5
Total Current Assets
-14,67813,38413,20714,91813,934
Property, Plant & Equipment
-12,83811,33110,3518,6227,665
Long-Term Investments
-273.1224.13199.74187.99194.8
Other Intangible Assets
-164.3631.88368.24243.341.53
Other Long-Term Assets
-199.7176.19197.04242.33284.36
Total Assets
-28,15325,74724,32424,21422,080

Liabilities

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Accounts Payable
-5,0074,3394,4964,9254,687
Accrued Expenses
-81.285.9571.7891.6576.77
Short-Term Debt
----3,6053,563
Current Portion of Long-Term Debt
-3,1803,2822,871412.96435
Current Portion of Leases
-9.511.789.519.9225.97
Current Income Taxes Payable
-71.5-11.8142.33-
Other Current Liabilities
-874650.14495.39397.13612.7
Total Current Liabilities
-9,2238,3707,9559,4959,401
Long-Term Debt
-2,5692,8402,7532,0471,385
Long-Term Leases
-8.616.519.144.0318.79
Long-Term Unearned Revenue
-2.31.61.71.71.7
Pension & Post-Retirement Benefits
-45.543.2527.4130.3528.75
Long-Term Deferred Tax Liabilities
-812.7782.33757.07709.68724.31
Other Long-Term Liabilities
--0.05--0-157.45
Total Liabilities
-12,66012,05311,50412,28711,717

Shareholders' Equity

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Common Stock
-912.7912.7919.35926926
Retained Earnings
--12,56011,70110,8119,240
Comprehensive Income & Other
-14,576217.31194.75187.48197.4
Total Common Equity
15,48915,48913,69012,81511,92410,364
Minority Interest
-3.653.444.062.33-0.6
Shareholders' Equity
15,49215,49213,69312,82011,92710,363
Total Liabilities & Equity
-28,15325,74724,32424,21422,080

Additional Metrics

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Total Debt
5,7665,7666,1515,6436,0895,428
Net Cash (Debt)
-5,524-5,524-5,929-5,440-5,886-5,084
Net Cash Growth
------
Net Cash Per Share
-60.50-60.53-64.96-59.17-63.57-54.91
Filing Date Shares Outstanding
91.3891.2291.2791.9492.692.6
Total Common Shares Outstanding
91.3891.2291.2791.9492.692.6
Working Capital
-5,4555,0145,2525,4234,533
Book Value Per Share
169.79169.79149.99139.40128.77111.92
Tangible Book Value
15,32415,32413,05812,44711,68110,362
Tangible Book Value Per Share
167.99167.99143.07135.39126.14111.90
Land
--948.11937.67937.67934.6
Buildings
--2,4192,2571,9321,921
Machinery
--11,46310,6339,1228,792
Construction In Progress
--2,7412,2521,868767.37